Abstract

A CINICAL STUDY TO EVALUATE THE EFFICACY OF VIRECHANA KARMA AND SIMHANADA GUGGULU IN THE MANAGEMENT OF AMAVATA

K.K Sharma, Srivastava Kumar Alok, Singh Vijeyta*, Shukla Datta Gyanendra

ABSTRACT

The disease Amavata is chronic in nature and affects mostly the middle aged group. It is one of the common debilitating diseases by the virtue of its chronicity and complications. The onset of disease is frequent during 4th and 5th decade of life with 80% of patients developing the disease between 20-50 years of age. Study shows that female are more sufferers than male and the ratio of occurrence between them is 3:1. It is also estimated that frequency is often associated with remission of the disease in last trimester with subsequent relapses after delivery. According to modern medicine, it can be correlated with Rheumatoid arthritis, which is a chronic autoimmune disease that causes inflammation and deformity of the joints. Due to their similar mode of presentations, the disease “Rheumatoid Arthritisâ€Â can be broadly grouped under the heading Amavata. Due to chronicity of disease, much prevalence in the society and lack of effective medicament, the disease is being chosen for the study with hope to develop effective medication for it.The aim of this study to evaluate the role of Virechana Karma and Simhanada Guggulu in the management of Amavata. To prove the practical approach of management of Virechana with Simhanada Guggulu in the management of Amavata, a randomized open clinical trial on 25 uncomplicated subjects of Rheumatoid Arthritis was conducted. Virechana has been carried out with with Gandharvahastadi Eranda Taila and Samshana drug ( Simhanada Guggulu) 500 mg will be given thrice in a day. In present study total 25 patients were selected. Stastical analysis showed better results in relieving the signs and symptoms of Amavata. The response was encouraging and has created scope for further studies.

Keywords: Amavata, Rheumatoid arthritis, Virechana, Simhanada Guggulu.